Severe hemolytic anemia caused by the NIPRO extracorporeal left ventricular assist device

Ikuko Shibasaki; Toshiyuki Kuwata; Go Tsuchiya; Hironaga Ogawa; Yasuyuki Yamada; Shigeru Toyoda; Teruo Inoue; Hirotsugu Fukuda

doi:10.1007/s11748-015-0621-0

Severe hemolytic anemia caused by the NIPRO extracorporeal left ventricular assist device

Gen Thorac Cardiovasc Surg. 2017 Apr;65(4):216-218. doi: 10.1007/s11748-015-0621-0. Epub 2016 Jan 6.

Authors

Ikuko Shibasaki¹, Toshiyuki Kuwata², Go Tsuchiya², Hironaga Ogawa², Yasuyuki Yamada², Shigeru Toyoda³, Teruo Inoue³, Hirotsugu Fukuda²

Affiliations

¹ Department of Cardiac and Vascular Surgery, Dokkyo Medical University School of Medicine, 880 Kitakobayashi, Mibu, Tochigi, 321-0293, Japan. sibasaki@dokkyomed.ac.jp.
² Department of Cardiac and Vascular Surgery, Dokkyo Medical University School of Medicine, 880 Kitakobayashi, Mibu, Tochigi, 321-0293, Japan.
³ Department of Cardiovascular Medicine, Dokkyo Medical University, School of Medicine, Tochigi, Japan.

PMID: 26739016
DOI: 10.1007/s11748-015-0621-0

Abstract

A 56-year-old woman with dilated cardiomyopathy underwent mitral and tricuspid annuloplasty, and simultaneous deployment of an extracorporeal left ventricular assist device (LVAD). Subsequently, she developed hemolytic anemia. Although the LVAD system was repeatedly exchanged and the mitral annular ring was removed, her hemolytic anemia did not improve. Finally, the NIPRO LVAD was replaced with Gyro Pump^®, and her anemia was ameliorated. It appears important to consider the possibility of hemolytic anemia as a LVAD-related complication, although it would be rare.

Keywords: Dilated cardiomyopathy; Hemolytic anemia; NIPRO LVAD.

Publication types

Case Reports

MeSH terms

Anemia, Hemolytic / etiology*
Device Removal
Equipment Failure
Female
Heart Failure / surgery*
Heart-Assist Devices / adverse effects*
Humans
Middle Aged